These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 12891224)
1. Pharmacokinetic drug interactions in children taking oxcarbazepine. Sallas WM; Milosavljev S; D'souza J; Hossain M Clin Pharmacol Ther; 2003 Aug; 74(2):138-49. PubMed ID: 12891224 [TBL] [Abstract][Full Text] [Related]
2. Drug interaction and pharmacokinetic modeling of oxcarbazepine in korean patients with epilepsy. Park KJ; Kim JR; Joo EY; Seo DW; Hong SB; Ko JW; Kim SR; Huh W; Lee SY Clin Neuropharmacol; 2012; 35(1):40-4. PubMed ID: 22246398 [TBL] [Abstract][Full Text] [Related]
4. Oxcarbazepine in infants and young children with partial seizures. Northam RS; Hernandez AW; Litzinger MJ; Minecan DN; Glauser TA; Mangat S; Zheng C; Souppart C; Sturm Y Pediatr Neurol; 2005 Nov; 33(5):337-44. PubMed ID: 16243221 [TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic children. Rodrigues C; Chiron C; Rey E; Dulac O; Comets E; Pons G; Jullien V Br J Clin Pharmacol; 2017 Dec; 83(12):2695-2708. PubMed ID: 28771787 [TBL] [Abstract][Full Text] [Related]
6. Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy. Rey E; Bulteau C; Motte J; Tran A; Sturm Y; D'Souza J; Markabi S; Pons G; Dulac O J Clin Pharmacol; 2004 Nov; 44(11):1290-300. PubMed ID: 15496647 [TBL] [Abstract][Full Text] [Related]
7. Overview of the clinical pharmacokinetics of oxcarbazepine. Flesch G Clin Drug Investig; 2004; 24(4):185-203. PubMed ID: 17516704 [TBL] [Abstract][Full Text] [Related]
8. Relative bioavailability, metabolism and tolerability of rectally administered oxcarbazepine suspension. Clemens PL; Cloyd JC; Kriel RL; Remmel RP Clin Drug Investig; 2007; 27(4):243-50. PubMed ID: 17358096 [TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate. Battino D; Estienne M; Avanzini G Clin Pharmacokinet; 1995 Nov; 29(5):341-69. PubMed ID: 8582119 [TBL] [Abstract][Full Text] [Related]
10. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Perucca E; Cloyd J; Critchley D; Fuseau E Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564 [TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics of oxcarbazepine. May TW; Korn-Merker E; Rambeck B Clin Pharmacokinet; 2003; 42(12):1023-42. PubMed ID: 12959634 [TBL] [Abstract][Full Text] [Related]
12. Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers. Mecarelli O; Vicenzini E; Pulitano P; Vanacore N; Romolo FS; Di Piero V; Lenzi GL; Accornero N Ann Pharmacother; 2004 Nov; 38(11):1816-22. PubMed ID: 15367726 [TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetic analysis for 10-monohydroxy derivative of oxcarbazepine in pediatric epileptic patients shows no difference between Japanese and other ethnicities. Sugiyama I; Bouillon T; Yamaguchi M; Suzuki H; Hirota T; Fink M Drug Metab Pharmacokinet; 2015 Apr; 30(2):160-7. PubMed ID: 25989891 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication. Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy. Kim DW; Gu N; Lee H; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Na HJ; Lee SK Int J Clin Pharmacol Ther; 2013 Oct; 51(10):780-6. PubMed ID: 23849326 [TBL] [Abstract][Full Text] [Related]
17. The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites. Rouan MC; Lecaillon JB; Godbillon J; Menard F; Darragon T; Meyer P; Kourilsky O; Hillion D; Aldigier JC; Jungers P Eur J Clin Pharmacol; 1994; 47(2):161-7. PubMed ID: 7859804 [TBL] [Abstract][Full Text] [Related]
18. Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepine. Hulsman JA; Rentmeester TW; Banfield CR; Reidenberg P; Colucci RD; Meehan JW; Radwanski E; Mojaverian P; Lin CC; Nezamis J Clin Pharmacol Ther; 1995 Oct; 58(4):383-9. PubMed ID: 7586929 [TBL] [Abstract][Full Text] [Related]
19. Oxcarbazepine adjunctive therapy in infants and young children with partial seizures. Piña-Garza JE; Espinoza R; Nordli D; Bennett DA; Spirito S; Stites TE; Tang D; Sturm Y Neurology; 2005 Nov; 65(9):1370-5. PubMed ID: 16275822 [TBL] [Abstract][Full Text] [Related]
20. Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy. Kim DW; Gu N; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Kim HS; Oh J; Lee SK Epilepsia; 2012 Jan; 53(1):e9-12. PubMed ID: 22091603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]